Press Release, Lund March 18, 2021 Today Hamlet Pharma is proud to announce new treatment advances in an experimental model of bladder cancer. A potent…
Read More
Extra bolagsstämman i Hamlet Pharma AB (publ) den 2 mars 2021 beslutade, i enlighet med styrelsens förslag, om en uppdelning (split) av de befintliga utestående…
Idag, den 2 mars 2021, hölls extra bolagsstämma i Hamlet Pharma AB (publ), som mot bakgrund av coronaviruset genomfördes enbart genom förhandsröstning med stöd av…
Pressmeddelande, Lund 29 januari, 2021 Aktieägarna i Hamlet Pharma AB (publ) kallas till extra bolagsstämma tisdagen den 2 mars 2021. Mot bakgrund av coronaviruset genomförs…
Hamlet Pharma AB (publ) föreslår införande av A- och B-aktier med rösträttsdifferentiering och kallar till extra bolagsstämma; Bill Hansson föreslås till ny styrelseledamot i Rolf…
Press Release, Lund January 22, 2021 Hamlet Pharma is proud to announce the inclusion of patients in the dose escalation study of bladder cancer in…
Dose-escalation studies have been performed to find the optimal dose of Alpha1H for future therapeutic studies. In the murine bladder cancer model, we observed a…
The Board of Hamlet Pharma AB has decided on a new date for the Annual General Meeting. The new date of the Annual General Meeting is Thursday,…
With Hamlet,from breast milk and the “foundation of life”to cancer therapy that improves the quality of life World Breastfeeding Week 2018 begins today, a worldwide,…
HAMLET Pharma has formally appointed Prof Catharina Svanborg, Chairman and founder of HAMLET Pharma, as Chief Medical Officer (CMO), to enable her to continue her…